Insulin secretion via pancreatic beta cell stimulation

The process described as "insulin secretion via pancreatic beta cell stimulation" refers to the highly regulated release of insulin from pancreatic beta cells in response to various stimuli, especially elevated blood glucose. The main trigger, glucose, is metabolized in the beta cell, leading to increased ATP/ADP ratio, closure of ATP-sensitive potassium channels (K_ATP), membrane depolarization, opening of voltage-gated calcium channels, and ultimately exocytosis of insulin-containing granules. This process also responds to hormones (GLP-1, GIP, etc.), neurotransmitters (such as acetylcholine), amino acids, and drugs. Many antidiabetic drugs target elements of this pathway to enhance insulin secretion for therapeutic benefit[1][2][3][4][5][9].

Other names

Insulin secretion (process)Glucose-stimulated insulin secretion (GSIS)Beta cell-mediated insulin release

Sulfonylureas: close ATP-sensitive potassium channels (K_ATP), triggering membrane depolarization and insulin exocytosis[1][9]. GLP-1 receptor agonists: increase cAMP and Ca^2+^ to enhance insulin secretion[1][5]. DPP-4 inhibitors: prevent breakdown of GLP-1, thus amplifying GLP-1 effects.